Skip to content
Ear Health Program

Djaalinj Waakinj

­­Ear Health team student Alumni

Cheryl Da Costa, MD

Hrehan Hakeem, MD

Symone Ishak, Honours

Emily Furness, Honours

Elizabeth Weeda, MD

Ann Thomas, MD

Caroline Fanning, MClinAud

Bernice Ong, MClinAud

Holly Richmond, Honours

Sarah Firns, MClinAud

Tara Prentice, MClinAud

Vaishali Varsana, MClinAud

Samantha Pan, MClinAud

Courtney Zoughby, MClinAud

Jacinta Lim, MClinAud

Kerry Majid, MClinAud


March 2022

Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study

Pneumonia is a leading cause of childhood mortality with Streptococcus pneumoniae a major contributor. Pneumococcal conjugate vaccines (PCVs) have been introduced into immunisation programs in many low- to middle-income countries yet there is a paucity of data evaluating the effectiveness in these settings. We assess the effectiveness of 13-valent PCV against hypoxic pneumonia, hospitalisation and other clinical endpoints in children <5 years living in Eastern Highlands Province, Papua New Guinea).

Published research Immunisation Infectious Diseases Ear Health Infectious Diseases Epidemiology Vaccine Trials Group Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases
February 2022

An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

Invasive meningococcal disease (IMD) causes significant morbidity and mortality worldwide with serogroup B being the predominant serogroup in Australia and other countries for the past few decades. The licensed 4CMenB vaccine is effective in preventing meningococcal B disease. Emerging evidence suggests that although 4CMenB impact on carriage is limited, it may be effective against gonorrhoea due to genetic similarities between Neisseria meningitidis and Neisseria gonorrhoeae.

Published research Infectious Diseases Ear Health Vaccine Trials Group
January 2022

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Pneumococcal disease outbreaks of vaccine preventable serotype 4 sequence type (ST)801 in shipyards have been reported in several countries. We aimed to use genomics to establish any international links between them.

Published research Infectious Diseases Ear Health